#news #biotech A fine-tuned gene editor that minimizes adverse consequences

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: A fine-tuned gene editor that minimizes adverse consequences .The molecular tool CRISPR-Cas9 can be used to treat inherited blood disorders, but this may cause unintended genetic alterations. A team led by MDC researchers Klaus Rajewsky and Van Trung Chu has now presented an approach in Science Advances that minimizes such adverse consequences.

from Biotechnology News – Biology News https://ift.tt/Q7D5hlu